chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 1/2  hour of receiving the vaccine I started to have a metallic taste in my mouth. I still have it today, over 3 weeks after receiving the vaccine.
Pt received an Adacel  immunization in her right arm on 08/27/2020.  She presented to the counseling window today with a swollen red right arm where the adacel had been administered (swollen around down to a few inches above her elbow).. She stated that Thursday night she had a fever (did not take her temp but felt it) and took motrin. The fever came down and the next day her arm was hard and sore.  Today the arm was soft but the swelling was there and she hadn't noticed the swelling down the arm till today. Upon inspection it seemed to be warm to the touch and swollen. I advised her to have her doctor look at her arm as well. She stated she did not want to see her MD. She was working at the store today so I had her stop by again before she left and the swelling seemed to be slightly reduced but still warm to the touch.  I will follow up with her tomorrow and she will talk to her MD if it gets worse. I also informed her of my concern of inflammation (cellulitis) and infection. She  wants to wait till Monday (8/31/2020) to talk to her MD.  I advised her to keep in touch with me and that I will follow up again tonight and tomorrow as well
White splashes underneath the skin in the leg and the knee; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISORDER (White splashes underneath the skin in the leg and the knee) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     The patient's past medical history included Reaction to previous exposure to any vaccine (shingles shot) and Flu.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced SKIN DISORDER (White splashes underneath the skin in the leg and the knee). At the time of the report, SKIN DISORDER (White splashes underneath the skin in the leg and the knee) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.
The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 37 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)
Vaccine thawed >10 weeks and administered.  4-6 weeks  past 10 week thawed date.   Pt developed no signs or symptoms of anything.
episodic shortness of breath, blurred vision, dizziness, episodic finger contractures to bilater hands
Patient received Pfizer Lot #EN6203 on 2/24/21 for his first dose and in error was given Moderna for his 2nd dose on 2/17/21 no treatment needed
Pt stated injection painful and soreness right after vaccine was given. Arm joint/soreness started the same evening especially when pt moved arm up and certain ways. Mobility limited. Stated may have flared up bursitis? Pain and soreness has been consistent to this day. Advised pt to contact their physican.
INTENSIFIED HEADACHE; LEFT ARM PAIN AND IMMOBILITY; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included left arm pain. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number.  No concomitant medications were reported. On an unspecified date, the subject experienced intensified headache, and left arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the intensified headache and left arm pain was not reported. This report was non-serious.
Hives - severe - all over body. Treatment: hydroxizine BID and BENADRYL. Also set up w/allergist for testing.
After being immunized, developed wheezing.  Returned to clinic to be evaluated, bilateral respiratory wheezing with coarse bronchi.  Several small urticarial lesions.  Received Benadryl 25MG by mouth and Albuterol via nebulizer.  Wheezing cleared.
No adverse event; Patient was administered a booster dose of the Moderna COVID-19 vaccine yesterday more than 12 hours after the initial vial puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a booster dose of the Moderna COVID-19 vaccine yesterday more than 12 hours after the initial vial puncture) and NO ADVERSE EVENT (No adverse event) in a 76-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE on 02-Mar-2021 and PFIZER BIONTECH COVID-19 VACCINE on 23-Mar-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 13-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a booster dose of the Moderna COVID-19 vaccine yesterday more than 12 hours after the initial vial puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered a booster dose of the Moderna COVID-19 vaccine yesterday more than 12 hours after the initial vial puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered a booster dose of the Moderna COVID-19 vaccine yesterday more than 12 hours after the initial vial puncture).    No concomitant medications were reported. The vaccine was initially punctured on 10-FEB-2023 and administered on 13-FEB-2023. No treatment medications were reported.
No additional AEs; HBP called in and reported that the improperly stored vaccine was administered.; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 13-OCT-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W011622, expiration date: 06-APR-2024, administered for prophylaxis (dose, anatomical location, and route of administration were not provided). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at -14 Celsius degrees up to -10 Celsius degrees (-11.9 Celsius degrees) for 42 minutes, no previous temperature excursion were reported (product storage error).  There were no adverse events reported (no adverse event).  This is one of four reports received from the same reporter.; Sender's Comments:  US-009507513-2210USA005958: US-009507513-2210USA005648: US-009507513-2210USA005741:
Patient was a resident on a LTC wing. Received Covid-19 vaccine on 1/13/21 & 2/10/21. Pt stated she felt phlegm in her throat 3/14/21. On 3/15/21 patient started having trouble swallowing, and started needing supplemental oxygen for low oxygen saturation and needing suctioned for c/o being unable to swallow.. ST eval showed no gag reflex and inability to swallow effectively or safely. Pt needed 5L/O2 and unable to hold saturations above 90%. Patient became ?comfort care?, and passed away 3/18/21.
shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not Provided          Concomitant information was not provided. Treatment information was not provided.
Information has been received from a physician concerning an approximately 60 day old male relative who "in the 2nd or 3rd week" of September 2007, received 2 ml oral dose of ROTATEQ vaccine live (human-bovine). In the 2nd or 3rd week of September 2007, 6 hours after receiving the vaccine the patient experienced a lot of gas. The patient sought unspecified medical attention. Subsequently, 48 hours after the dose, he recovered from a lot of gas. A product quality complaint was not reported. No further information was available. Additional information has been requested.
This spontaneous report was received from a nurse practitioner who referred to an unspecified number of patients of unknown demographics. No information regarding the patients' pertinent medical history, concomitant medications and drug reactions or allergies was provided. On unknown dates, the patients were administered improperly stored doses of ROTATEQ (route of administration defaulted to oral, lot# M011832 and expiration date: 24-JAN-2018; dose was not reported) as prophylaxis. The vaccines were stored in the temperature between 47 degrees Fahrenheit (F) to 77F (51.1F) for 2 hours, with a previous temperature excursion of more than 47F and less than 77F (46.6F) for 15 hours. The temperature excursions were detected by a data logger. No adverse effects were reported. No product quality complaint was involved. This is one of three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA001313: US-009507513-1707USA001314.
Parents state that about 2 or 3 hours after the vaccines this morning, they noticed that her legs from the upper thighs to the bottom of her feet were bright red and warm, did states that it was this way especially on the bottom of her feet.  This redness and warmth lasted for about 30 minutes.  They noticed the red dots on her lower legs shortly thereafter.  Parents report that other than the rash, she has been cranky and not wanting to eat.  A little better with Tylenol on board.  Still wetting diapers well.  She has had no difficulty breathing or swallowing. There is a petechial rash to bilateral lower legs which may be an abnormal reaction to the vaccines or possibly mechanical in etiology.  Exam is otherwise reassuring.  Will report to VAERS.  No need to amend future vaccine schedule.  Discussed possible etiologies today with parents.  Monitoring and red flags discussed in detail.
Information has been received on 02-JAN-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 09-JUN-2009, a healthcare provider at a medical center administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 10-MAR-2010, the patient was treated by a healthcare provider at a vision clinic for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is not recovered. The causality of the events is related. Additional information has been requested.
Approx. 4 weeks after receiving the first COVID-19 vaccine dose, and 8 days after receiving the second dose, I began experiencing heart palpitations and arrythmias that have persisted ever since (2 years and counting). It appears that these symptoms, including skipped beats, extra beats, and 120+ bpm at rest, are consistent with Myocarditis and/or Long QT Syndrome, which can be brought on by Myocarditis.
Sore, swelling, redness. Pt. took 1 MOTRIN.
blood clots behind right knee and lung; prescribed Eliquis 5mg  (haven't started just yet)1 tablet BID; Eliquis for 6 months, but potentially blot clots for the rest of his life  weak, low oxygen levels, fatigue (still til this day 13 days later);  prescribed Eliquis 5mg  (haven't started just yet)1 tablet BID; Eliquis for 6 months, but potentially blot clots for the rest of his life  chills, 101 F fever, body aches, fatigue;  recovered naturally; symptoms are gone
Pt. had seizure activity approximately one day following the administration of Adacel and Menactra. Paramedics took her to the ER. Diagnosed with Grand Mal seizure X 1.  No further seizure activity reported. This was a new onset. 03/30/07-records received from facility for DOS 03/08/07-DX:Gran mal seizure.  Experienced seizure in evening lasting 3-4 minutes. Did not become oriented for about 1 hour. EMS stated she was agitated and uncooperative. Denies headache, neck pain no fever has been dieting and using diet pills. PE: WNL.
April 4, 2021 could not catch my breath.  Later analysis (scan) showed large pulmonary embolism and small emboli  May 5, 2021 venous doppler showed "extensive" DVT in left leg.  Immediately admitted to Hospital ER.  Stayed two nights.  Put on heparin, then lovenox, then Eliquis on my discharge.  Currently on Eliquis for at least six months.  Left calf still swollen.  Blood clot specialist says the PE and DVT were "unprovoked."  Cause unknown.
about 3 hours after shot, experienced severe vertigo and dizziness, causing nausea. 36 hours later still moderate dizziness and occasionally extreme dizziness. no treatment except rest. also moderate pain in left ear beginning 12 hours after shot.
56 male in his usual state of health abruptly developed generalized body rash and easy fatigue, weakness approximately 4 weeks after receiving his seasonal flu vaccination through Employee Health. He presented to Dermatology for evaluation of his rash. Patient was admitted to the Hospital on November 11, 2013 for further work up and evaluation. "HOSPITAL COURSE (focused): Pt presented with B/L LE weakness and had suspicion of GBS, pt was evaluated by Neurology and they R/O GBS. Pt found to have anemia and AKI, hemoccult stool test negative. Pt was transfused, Hb stable post transfusion. Nephrology consulted they want to follow as out pt. Pt wanted to go home. Discharged in stable condition with close F/U."
LOWER BACK PAIN; NECK PAIN; STIFF ELBOW/ARM WHERE HE GOT HIS SHOT IS STIFF; FEEL SLUGGISH; DID NOT FEEL WELL; JOINT PAIN/SORE ELBOW/ARM WHERE HE GOT HIS SHOT IS SORE; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's past medical history included back surgery, and concurrent conditions included alcohol user, non-smoker, and sinus allergies, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 30-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-AUG-2021, the subject experienced lower back pain. On 01-AUG-2021, the subject experienced neck pain. On 01-AUG-2021, the subject experienced stiff elbow/arm where he got his shot is stiff. On 01-AUG-2021, the subject experienced feel sluggish. On 01-AUG-2021, the subject experienced did not feel well. On 01-AUG-2021, the subject experienced joint pain/sore elbow/arm where he got his shot is sore. On 01-AUG-2021, the subject experienced fever. On 01-AUG-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, headache, lower back pain, neck pain, stiff elbow/arm where he got his shot is stiff, and joint pain/sore elbow/arm where he got his shot is sore, and the outcome of did not feel well and feel sluggish was not reported. This report was non-serious.
Patient administered PROQUAD vaccine (MMRV) instead of MMR. Also rec'd varicella that day. No s/s or tx noted/given.
Dose of expired COVID vaccine given to patient. Consulted Pfizer for instructions, told to schedule for repeat dose. Mom notified upon discovery, patient scheduled to receive repeat dose. No harm to patient.
Same symptoms as after 1st vaccine.  starting about 12 hours post injection I developed chills, fever, could not get warm, joint pain-specifically low back, hips, shoulders, achy all over, headache, nausea.   Slept poorly.  Woke up the next morning with headache, achy.  All symptoms passed about 18 hours post vaccine.  of note I have never been tested for covid but my husband had a severe case in March.  I tested positive for antibodies twice with the most recent time 12/14/20.  I have never had symptoms of covid (until I got the vaccine)
White film on top of tongue. White and erythematic ulcers, tiny in size on sides of tongue and hard palate. Inflamed left tonsil. No ulcers on tonsils or post pharnyx. reports headaches. sinuses are clear.
Constant headache, memory loss. 1st dose was Moderna and second dose was Pfizer.
uncontrollable crying w/in 2 days p/vax; t>1-2; also had diarrhea;
Dizzy; She is not feeling well; When she went home she fell, she had a terrible fall and she got a terrible bruise on her head; When she went home she fell, she had a terrible fall and she got a terrible bruise on her head; Tired; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A female patient of an unspecified age received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient experienced dizzy, she was not feeling well, when she went home she fell, she had a terrible fall and she got a terrible bruise on her head, she also tired. The outcome of the events was unknown.   Information about lot/batch number has been requested.
itching all over body; This case was reported by a pharmacist via call center representative and described the occurrence of generalized pruritus in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number E523B, expiry date 5th November 2021) for prophylaxis.   On 8th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 9th August 2019, 1 days after receiving Shingrix, the patient experienced generalized pruritus. In August 2019, the outcome of the generalized pruritus was recovered/resolved.   It was unknown if the reporter considered the generalized pruritus to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left arm. The next morning after receiving Shingrix, the patient experienced itching all over her body which lasted for one week. The reporter consented to follow up.